VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Amgen Inc. vs Sartorius Stedim Biotech S.A.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Sartorius Stedim Biotech S.A.
DIM · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Sartorius Stedim Biotech S.A.'s moat claims, evidence, and risks.
View DIM analysisComparison highlights
- Moat score gap: Sartorius Stedim Biotech S.A. leads (80 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Sartorius Stedim Biotech S.A. has 2 segments (75% in Sterile single-use bioprocessing consumables).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Sartorius Stedim Biotech S.A. has 6 across 3.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Sartorius Stedim Biotech S.A.
Sterile single-use bioprocessing consumables
Sterile single-use bioprocessing consumables (bags, filters, fluid management components)
Global
Biopharmaceutical manufacturers and CDMOs
Consumables supplier (single-use)
75%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Sartorius Stedim Biotech S.A. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Sartorius Stedim Biotech S.A. segments
Full profile >Sterile single-use bioprocessing consumables
Oligopoly
Bioprocessing equipment, systems, and software/services
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.